MGMT and neoplasm: Kaplan–Meier curves revealed median OS of 10.5 months (95% CI: 7.2–12.5) for patients whose tumours were methylated at the MGMT promoter compared with a median of 9.7 months (95% CI: 7.6–11.4) for patients with an unmethylated MGMT promoter (Figure 3).